These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9151812)

  • 1. The antiretrovirus drug 3'-azido-3'-deoxythymidine increases the retrovirus mutation rate.
    Julias JG; Kim T; Arnold G; Pathak VK
    J Virol; 1997 Jun; 71(6):4254-63. PubMed ID: 9151812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Azacytidine and RNA secondary structure increase the retrovirus mutation rate.
    Pathak VK; Temin HM
    J Virol; 1992 May; 66(5):3093-100. PubMed ID: 1373201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deoxyribonucleoside triphosphate pool imbalances in vivo are associated with an increased retroviral mutation rate.
    Julias JG; Pathak VK
    J Virol; 1998 Oct; 72(10):7941-9. PubMed ID: 9733832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of biphalin and AZT on murine Friend leukemia virus infection in vitro.
    Tang JL; Lipkowski AW; Specter S
    Int J Immunopharmacol; 1998 Sep; 20(9):457-66. PubMed ID: 9818790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of amino acid variation at human immunodeficiency virus type 1 reverse transcriptase residue 210 for zidovudine susceptibility.
    Harrigan PR; Kinghorn I; Bloor S; Kemp SD; Nájera I; Kohli A; Larder BA
    J Virol; 1996 Sep; 70(9):5930-4. PubMed ID: 8709214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double hairpin structure is necessary for the efficient encapsidation of spleen necrosis virus retroviral RNA.
    Yang S; Temin HM
    EMBO J; 1994 Feb; 13(3):713-26. PubMed ID: 8313915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New lipophilic alkyl/acyl dinucleoside phosphates as derivatives of 3'-azido-3'-deoxythymidine: inhibition of HIV-1 replication in vitro and antiviral activity against Rauscher leukemia virus infected mice with delayed treatment regimens.
    Schwendener RA; Gowland P; Horber DH; Zahner R; Schertler A; Schott H
    Antiviral Res; 1994 May; 24(1):79-93. PubMed ID: 7944315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different properties of wild type and drug-resistant mutants of human immunodeficiency virus type 1 reverse transcriptase in vitro.
    Ijichi K; Fujiwara M; Shigeta S; Konno K; Yokota T; Baba M
    Microbiol Immunol; 1996; 40(5):353-8. PubMed ID: 8805099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase.
    Tisdale M; Kemp SD; Parry NR; Larder BA
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5653-6. PubMed ID: 7685907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: substitutions, frameshifts, and hypermutations.
    Pathak VK; Temin HM
    Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6019-23. PubMed ID: 2201018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic rearrangements occurring during a single cycle of murine leukemia virus vector replication: characterization and implications.
    Parthasarathi S; Varela-Echavarría A; Ron Y; Preston BD; Dougherty JP
    J Virol; 1995 Dec; 69(12):7991-8000. PubMed ID: 7494312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro selection of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine.
    Dianzani F; Antonelli G; Turriziani O; Dong G; Capobianchi MR; Riva E
    Antiviral Res; 1992 May; 18(1):39-52. PubMed ID: 1384427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of murine leukemia virus reverse transcriptase deoxyribonucleoside triphosphate-binding site in retroviral replication and in vivo fidelity.
    Halvas EK; Svarovskaia ES; Pathak VK
    J Virol; 2000 Nov; 74(22):10349-58. PubMed ID: 11044079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy.
    Iversen AK; Shafer RW; Wehrly K; Winters MA; Mullins JI; Chesebro B; Merigan TC
    J Virol; 1996 Feb; 70(2):1086-90. PubMed ID: 8551567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel point mutation at position 156 of reverse transcriptase from feline immunodeficiency virus confers resistance to the combination of (-)-beta-2',3'-dideoxy-3'-thiacytidine and 3'-azido-3'-deoxythymidine.
    Smith RA; Remington KM; Preston BD; Schinazi RF; North TW
    J Virol; 1998 Mar; 72(3):2335-40. PubMed ID: 9499094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the Delta67 complex of mutations in human immunodeficiency virus type 1 reverse transcriptase on nucleoside analog excision.
    Boyer PL; Imamichi T; Sarafianos SG; Arnold E; Hughes SH
    J Virol; 2004 Sep; 78(18):9987-97. PubMed ID: 15331732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses.
    Trono D
    J Virol; 1992 Aug; 66(8):4893-900. PubMed ID: 1378513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3'-Azido-3'-deoxythymidine (AZT) and AZT-resistant reverse transcriptase can increase the in vivo mutation rate of human immunodeficiency virus type 1.
    Mansky LM; Bernard LC
    J Virol; 2000 Oct; 74(20):9532-9. PubMed ID: 11000223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of murine AIDS by combination of AZT and dideoxycytidine 5'-triphosphate.
    Fraternale A; Casabianca A; Rossi L; Chiarantini L; Brandi G; Aluigi G; Schiavano GF; Magnani M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jun; 12(2):164-73. PubMed ID: 8680888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and genetical analysis of AZT-resistant HIV-mutants.
    Biesert L; Zimmermann F; Schröder B; Matthes E; Suhartono H; Dietrich U; Rübsamen-Waigmann H
    Behring Inst Mitt; 1991 Jul; (89):74-80. PubMed ID: 1930105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.